ReviewWorld journal of hepatology2020
Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome - what we know so far.
Review in World journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 28 citations in OpenAlex.
- Clinical manifestations of SARS-CoV-2 Omicron infection is associated with the stage of liver cirrhosis.BMC infectious diseases · 2025Article
- Microfluidic point-of-care testing device for multiplexed detection of liver function blood markers.Biomedical optics express · 2024Article
- Chronic active Epstein-Barr virus infection with reinfection of SARS-CoV-2: a case report.Virology journal · 2024Article
- COVID-19-induced liver injury in infants, children, and adolescents.World journal of clinical pediatrics · 2023Review
- COVID-19-related liver injury: Focus on genetic and drug-induced perspectives.World journal of virology · 2023Article
- Liver injury in COVID-19: A minireview.World journal of gastroenterology · 2022Review
- Diabetes Mellitus May Exacerbate Liver Injury in Patients with COVID-19: A Single-Center, Observational, Retrospective Study.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2022Article
- COVID-19 liver and gastroenterology findings: AnWorld journal of hepatology · 2022Article
- Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study.World journal of gastroenterology · 2021Article
- Factors Associated With COVID-19 Disease Severity in US Children and Adolescents.Journal of hospital medicine · 2021Article
- Herbal and dietary supplement induced liver injury: Highlights from the recent literature.World journal of hepatology · 2021Review
- Impact of COVID-19 on liver.World journal of clinical cases · 2021Review
- Liver function test abnormalities in COVID-19 patients and factors affecting them - a retrospective study.Clinical and experimental hepatology · 2021Article
- Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence.World journal of hepatology · 2021Review
- Acute icteric hepatitis as the first isolated symptom of COVID-19.BMJ case reports · 2021Article
- Epstein-Barr Virus Coinfection in COVID-19.Journal of investigative medicine high impact case reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 2019 novel coronavirus disease (COVID-19) pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a serious threat to global public health. Although primarily, the infection causes lung injury, liver enzyme abnormalities have also been reported to occur during the course of the disease. We conducted an extensive literature review using the PubMed database on articles covering a broad range of issues related to COVID-19 and hepatic injury. The present review summarizes available information on the spectrum of liver involvement, the possible mechanisms and risk factors of liver injury due to SARS-CoV-2 infection, and the prognostic significance of the presence of liver injury. Hopefully, this review will enable clinicians, especially the hepatologists, to understand and manage the liver derangements they may encounter in these patients better and provide guidance for further studies on the liver injury of COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.